Overview
DEND syndrome stands for Developmental delay, Epilepsy, and Neonatal Diabetes. It is a very rare condition that affects babies from birth. The name describes the three main problems it causes: serious developmental delays, hard-to-control seizures, and diabetes that starts in the first few months of life. It is sometimes called 'DEND syndrome' or referred to as part of a group of conditions called 'neonatal diabetes mellitus with neurological features.' A milder version, called intermediate DEND (iDEND) syndrome, causes diabetes and some developmental delay but fewer or no seizures. DEND syndrome is caused by changes (mutations) in genes that control a special channel in cells called the ATP-sensitive potassium channel, or KATP channel. This channel plays a key role in the pancreas (which makes insulin to control blood sugar) and in the brain and muscles. When the channel does not work properly, the pancreas cannot release insulin correctly, leading to diabetes. At the same time, the brain is affected, causing seizures and slowed development. For many years, children with DEND syndrome were treated with insulin injections for their diabetes. A major breakthrough came when doctors discovered that a type of medication called sulfonylureas — especially glibenclamide (also known as glyburide) — can treat both the diabetes and, in some cases, improve the brain symptoms. This has changed the outlook for many children with this condition, though the neurological problems can be harder to treat than the diabetes.
Also known as:
Key symptoms:
Diabetes diagnosed in the first 6 months of life (neonatal diabetes)Frequent or hard-to-control seizures (epilepsy)Significant developmental delay — slower to reach milestones like sitting, walking, and talkingIntellectual disability ranging from mild to severeMuscle weakness or low muscle tone (hypotonia)Movement problems or poor coordinationDifficulty feeding as a newbornHigh blood sugar levels (hyperglycemia) from birthSmall size or poor growthAbnormal eye movements in some cases
Clinical phenotype terms (19)— hover any for plain English
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for DEND syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for DEND syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for DEND syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to DEND syndrome.
Community
No community posts yet. Be the first to share your experience with DEND syndrome.
Start the conversation →Latest news about DEND syndrome
No recent news articles for DEND syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Should my child switch from insulin to a sulfonylurea medication, and what benefits or risks should I expect?,What is the best way to monitor and manage my child's blood sugar at home?,What seizure medications are most appropriate for my child, and what should I do if a seizure lasts more than 5 minutes?,What early intervention therapies (physical, occupational, speech) should my child start, and how soon?,Are there any clinical trials or new treatments for DEND syndrome that my child might be eligible for?,What is the long-term outlook for my child, and what level of independence might they achieve?,Should other family members be tested for mutations in KCNJ11 or ABCC8?
Common questions about DEND syndrome
What is DEND syndrome?
DEND syndrome stands for Developmental delay, Epilepsy, and Neonatal Diabetes. It is a very rare condition that affects babies from birth. The name describes the three main problems it causes: serious developmental delays, hard-to-control seizures, and diabetes that starts in the first few months of life. It is sometimes called 'DEND syndrome' or referred to as part of a group of conditions called 'neonatal diabetes mellitus with neurological features.' A milder version, called intermediate DEND (iDEND) syndrome, causes diabetes and some developmental delay but fewer or no seizures. DEND synd
How is DEND syndrome inherited?
DEND syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does DEND syndrome typically begin?
Typical onset of DEND syndrome is neonatal. Age of onset can vary across affected individuals.